Cambridge Investment Research Advisors, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History

Cambridge Investment Research Advisors, Inc.

$27.1 Billion
Q2 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Vaneck ETF Tr Vaneck Pharmaceu stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 4,828 shares of PPH stock, worth $458,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,828

Previous 2,847 69.58%

Holding current value

$458,032

Previous $258,000 71.32%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$84.87 - $93.23 $168,127 - $184,688	1,981 Added 69.58%	4,828 $442,000
Q1 2024 Apr 24, 2024	BUY	$82.63 - $90.89 $235,247 - $258,763	2,847 New	2,847 $258,000
Q2 2023 Jul 13, 2023	BUY	$75.02 - $80.55 $242,164 - $260,015	3,228 Added 49.1%	9,802 $772,000
Q1 2023 May 11, 2023	SELL	$73.68 - $79.63 $1.47 Million - $1.59 Million	-20,019 Reduced 75.28%	6,574 $510,000
Q4 2022 Feb 08, 2023	BUY	$67.31 - $79.26 $1.57 Million - $1.85 Million	23,339 Added 717.24%	26,593 $2.07 Million
Q3 2022 Oct 17, 2022	SELL	$66.73 - $77.98 $51,181 - $59,810	-767 Reduced 19.07%	3,254 $0
Q2 2022 Jul 13, 2022	BUY	$72.65 - $83.96 $292,125 - $337,603	4,021 New	4,021 $0

Others Institutions Holding PPH

# of Institutions

148

Shares Held

4.87M

Call Options Held

10.7K

Put Options Held

44.1K

View Full List

About VANECK ETF TR VANECK PHARMACEU

Ticker PPH
Sector ETFs
Industry ETFs

More about PPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Vaneck ETF Tr Vaneck Pharmaceu Transaction History